This webinar series will be held monthly from 6-7 pm ET and moderated by members of the SCAI Bifurcation Club and Dr. Tanveer Rab. Each session will present two 20-minute cases, with an emphasis on imaging. The discussions will be case-based and focus predominantly on procedural approaches and techniques. There are no didactic lectures except for guidelines or technical updates. Register now for the entire series.
Upon completion of these activities, participants will be able to:
- Assess and apply procedural techniques to treat bifurcation lesions
- Examine imaging modalities and their best applications
- Discuss challenging bifurcation cases
- Explain treatment of bifurcation lesions in the presence of cardiogenic shock and STEMI
- Case: Step by Step DK Crush—Dr. Chen
- Case: Calcified Bifurcation:Two Stents or One? —Dr. Kini
- Case: Double DK Crush—Dr. Riley
The Society for Cardiovascular Angiography and Interventions (SCAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
SCAI designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 medical knowledge MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Watch the content and complete the evaluation to obtain credit.
Acknowledgement of Commercial Support
This activity is supported by an unrestricted educational grant from Medtronic.
Individuals in control of content have no relevant relationships with ineligible companies.
SCAI's Independent Content
As a provider of continuing medical education through the Accreditation Council for Continuing Medical Education (ACCME), it is the Society’s policy to ensure balance, independence, objectivity, and scientific rigor in all its activities.
SCAI activities are developed by the SCAI planners prior to and independent of commercial support. Members of the Education Committee reviewed and approved this activity. If planners had relevant financial relationships, the agenda was peer reviewed by a member with no relevant financial relationships.
Mitigation of Relevant Financial Relationships
All participating planners, reviewers, faculty, and staff are required to disclose to SCAI all financial relationships with ineligible companies. SCAI identifies relevant financial relationships and mitigates them before the activity begins.
Content Validation Statement
SCAI accepts the following Content Validation Statements and expects all persons involved in its professional education activities to abide by these statements for clinical care recommendations. All clinical and pharmacological recommendations are based on evidence accepted within the medical profession as adequate jurisdiction for their indications and contradictions in patient care. All research referenced to support or justify patient care recommendations conforms to accepted standards of experimental design, data collection and analysis. SCAI does not promote recommendations, treatment, or manners of practicing medicine that are not within the definition of accredited continuing education or known to have risks or dangers that outweigh the benefits or known to be ineffective in the treatment of patients. SCAI actively promotes improvements in health care and NOT proprietary interests of an ineligible company. SCAI's educational content is free of marketing or sales of products or services. Faculty will not actively promote or sell products or services that serve their professional or financial interests during accredited education. SCAI encourages faculty to identify investigational products or off-label uses of products regulated by the U.S. Food and Drug Administration (FDA), at first mention and where appropriate in the content.
Learning opportunities from SCAI for the interventional cardiology team.